Episodes
Friday Jan 20, 2023
Complex Patient Case - Women’s Health + Contraception
Friday Jan 20, 2023
Friday Jan 20, 2023
Reason for Visit: JS was referred by her PCP to the ambulatory care pharmacist for contraceptive counseling.
Chief Complaint: “I think I’m leaning more towards the pill, but I’m really open to anything. It’s also itchy again down there, probably another yeast infection.”
Guest Author: Elizabeth Salisbury, PharmD
Expert Panelists: Ashley Meredith, PharmD, MPH, BCACP; Rebecca Stone, PharmD, BCACP, and Sally Rafie, PharmD, BCPS
Wanna earn continuing pharmacy education (CPE) for this program? Be sure to log-in to the iForumRx website, review the case, listen to the podcast, and scroll to the bottom of the page to claim CE.
Check out the Birth Control Pharmacist website.
--------
Friday Sep 02, 2022
Treating mild hypertension during pregnancy: Time for a new CHAPter!
Friday Sep 02, 2022
Friday Sep 02, 2022
Most practitioners won’t hesitate to start drug therapy in an adult patient with chronically elevated blood pressure (BP) … except, perhaps, if the patient is pregnant. In this vulnerable population, we frequently take a “wait-and-see” approach and withhold therapy unless the BP elevations become severe. But is this the right decision?
Guest Authors: Timothy D. Gladwell, PharmD, BCPS, BCACP and Scott Baker, PharmD, BCPS
Music by Good Talk
Wednesday Feb 09, 2022
Assessing HER Acceptability of Contraception
Wednesday Feb 09, 2022
Wednesday Feb 09, 2022
More than half of women in the United States aged 15 to 49 years use a form of contraception. However, many women discontinue use during the first 12 months. Reasons for discontinuation include inconvenience, method failure, adverse effects, and cost. But another potential factor that is not as well-studied is the sexual acceptability of the contraceptive method.
Guest Authors: Katherine Harte, PharmD and Allison Zuern, PharmD, BCPS, CDCES
Music by Good Talk
Tuesday Aug 31, 2021
Up the Creek Without a Paddle? Look to Your Pharmacist to Bridge-It
Tuesday Aug 31, 2021
Tuesday Aug 31, 2021
Nearly half of all pregnancies are unintended and a high percentage of unwanted pregnancies lead to an abortion. Reducing the number of unintended pregnancies and increasing the use of effective birth control are two public health priorities. Could the implementation of pharmacist contraception prescribing combined with EC on the same day help “bridge the gap?”
Guest Authors: Ashley H. Meredith, PharmD, MPH, BCACP, BCPS, CDCES and Veronica P. Vernon, PharmD, BCPS, BCACP, NCMP
Music by Good Talk
Friday Mar 16, 2018
Can We KEEP Perimenopausal Women Sexually Satisfied?
Friday Mar 16, 2018
Friday Mar 16, 2018
Female sexual dysfunction (FSD) effects women of all ages but is common among perimenopausal / postmenopausal women and may be related to a reduction in circulating estrogen. Oral estrogens increase sex hormone-binding globulin (SHBG) which lowers available free testosterone and thus may negatively impact sexual function.Transdermal estrogens are typically preferred because they lack a high first-pass effect and are not associated with risk of thromboembolic events. However, additional research – directly comparing oral and transdermal preparations – was needed. An ancillary study of the Kronos Early Estrogen Prevention Study (KEEPS) did just that - examined the impact of oral and transdermal estrogens on sexual functioning.
Guest Authors: Stefanie C. Nigro, PharmD, BCACP and Christine Dimanculangan, Pharm.D.
Music by Good Talk
Friday Jan 08, 2016
Preventing Gestational Diabetes with Myo-Inositol: Ready for Prime Time?
Friday Jan 08, 2016
Friday Jan 08, 2016
With increased emphasis on disease prevention, gestational diabetes (GDM) is worthy of more attention. The incidence is on the rise not only in the United States (U.S.) but worldwide. Complications of GDM such as preeclampsia, cesarean delivery, neonatal hypoglycemia, macrosomia, and birth trauma negatively impact maternal and fetal health. Is a readily available, non-prescription dietary supplement the answer? Recent investigations have examined the use of myo-inositol for GDM prevention, with positive results.